Lexaria Bioscience Corp (LEXX)
2.37
+0.16
(+7.24%)
USD |
NASDAQ |
Dec 26, 16:00
2.35
-0.02
(-0.84%)
Pre-Market: 20:00
Lexaria Bioscience Cash from Operations (Quarterly): -1.892M for Aug. 31, 2024
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 17.03M |
| Edesa Biotech Inc | -0.967M |
| Xenon Pharmaceuticals Inc | -51.15M |
| ESSA Pharma Inc | -3.366M |
| ImmunoPrecise Antibodies Ltd | -1.647M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0696M |
| Free Cash Flow | -5.148M |
| Free Cash Flow Per Share (Quarterly) | -0.1248 |
| Free Cash Flow to Equity (Quarterly) | -1.961M |
| Free Cash Flow Yield | -17.59% |